Format
Sort by
Items per page

Send to

Choose Destination

Best matches for D’Cruz D[au]:

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Gordon C et al. Rheumatology (Oxford). (2018)

Relapsing polychondritis: a clinical review for rheumatologists. Kingdon J et al. Rheumatology (Oxford). (2018)

Neurological Manifestations of IgG4-Related Disease. Baptista B et al. Curr Treat Options Neurol. (2017)

Search results

Items: 1 to 50 of 313

1.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.

Tieu J, Smith R, Basu N, Brogan P, D'Cruz D, Dhaun N, Flossmann O, Harper L, Jones RB, Lanyon PC, Luqmani RA, McAdoo SP, Mukhtyar C, Pearce FA, Pusey CD, Robson JC, Salama AD, Smyth L, Watts RA, Willcocks LC, Jayne DRW.

Rheumatology (Oxford). 2020 Apr 1;59(4):e24-e32. doi: 10.1093/rheumatology/kez640. No abstract available.

PMID:
32096545
2.

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary.

Tieu J, Smith R, Basu N, Brogan P, D'Cruz D, Dhaun N, Flossmann O, Harper L, Jones RB, Lanyon PC, Luqmani RA, McAdoo SP, Mukhtyar C, Pearce FA, Pusey CD, Robson JC, Salama AD, Smyth L, Watts RA, Willcocks LC, Jayne DRW.

Rheumatology (Oxford). 2020 Apr 1;59(4):727-731. doi: 10.1093/rheumatology/kez632. No abstract available.

PMID:
32096542
3.

Internal Jugular Vein Thrombosis: A Serious Presentation of Behçet Disease.

Sanyal K, Ashford NS, DʼCruz D.

J Clin Rheumatol. 2020 Jan;26(1):e1. doi: 10.1097/RHU.0000000000000784. No abstract available.

PMID:
31860542
4.

General Movement assessment and neurodevelopmental trajectory in extremely preterm infants with hypothyroxinaemia of prematurity (THOP).

Goel D, Luig M, Maheshwari R, D'Cruz D, Goyen TA.

Early Hum Dev. 2019 Oct 24:104886. doi: 10.1016/j.earlhumdev.2019.104886. [Epub ahead of print]

PMID:
31668678
5.

Sneddon syndrome associated with two novel ADA2 gene mutations.

Tull TJ, Martin B, Spencer J, Sangle S, Chua S, McGrath JA, D'Cruz DP, McGibbon DH.

Rheumatology (Oxford). 2019 Oct 25. pii: kez446. doi: 10.1093/rheumatology/kez446. [Epub ahead of print] No abstract available.

PMID:
31652311
6.

Liberal hemoglobin threshold affects cerebral arterial pulsed Doppler and cardiac output, not cerebral tissue oxygenation: a prospective cohort study in anemic preterm infants.

Jani P, Lowe K, Hinder M, Galea C, D'Çruz D, Badawi N, Tracy M.

Transfusion. 2019 Oct;59(10):3093-3101. doi: 10.1111/trf.15452. Epub 2019 Jul 16.

PMID:
31313334
7.

Pulmonary Complications of Systemic Lupus Erythematosus.

Hannah JR, D'Cruz DP.

Semin Respir Crit Care Med. 2019 Apr;40(2):227-234. doi: 10.1055/s-0039-1685537. Epub 2019 May 28.

PMID:
31137062
8.

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, Danda D, D'cruz D, Espinosa G, Frances C, Jayne D, Ooi KK, Kucharz EJ, Lebovics R, Marie I, Moulis G, Peng S, Sharma A, Suzuki N, Tanaka T, Van Vollenhoven R, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Joint Bone Spine. 2019 May;86(3):363-368. doi: 10.1016/j.jbspin.2018.11.001. Epub 2018 Nov 15.

PMID:
30448476
9.

Idiopathic aortitis presenting as pyrexia of unknown origin and delirium.

Shukla P, Sen A, Bhalla A, D'Cruz D.

Br J Hosp Med (Lond). 2018 Oct 2;79(10):586-587. doi: 10.12968/hmed.2018.79.10.586. No abstract available.

PMID:
30290748
10.

Spatiotemporal segregation of human marginal zone and memory B cell populations in lymphoid tissue.

Zhao Y, Uduman M, Siu JHY, Tull TJ, Sanderson JD, Wu YB, Zhou JQ, Petrov N, Ellis R, Todd K, Chavele KM, Guesdon W, Vossenkamper A, Jassem W, D'Cruz DP, Fear DJ, John S, Scheel-Toellner D, Hopkins C, Moreno E, Woodman NL, Ciccarelli F, Heck S, Kleinstein SH, Bemark M, Spencer J.

Nat Commun. 2018 Sep 21;9(1):3857. doi: 10.1038/s41467-018-06089-1.

11.

Outcomes of infants born at borderline viability (23-25 weeks gestation) who received cardiopulmonary resuscitation at birth.

Goel D, D'cruz D, Jani P.

J Paediatr Child Health. 2019 Apr;55(4):399-405. doi: 10.1111/jpc.14210. Epub 2018 Sep 9.

PMID:
30198164
12.

High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus.

Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, D'Cruz DP, Carr-White G, Marber M, Schnoes K, Arendt C, Klingel K, Vogl TJ, Zeiher AM, Nagel E, Puntmann VO.

Ann Rheum Dis. 2018 Nov;77(11):1590-1598. doi: 10.1136/annrheumdis-2018-213661. Epub 2018 Aug 4.

PMID:
30077990
13.

Analysis of the chief complaints of older patients seeking chiropractic care at a teaching clinic and potential implications for clinical education.

D'cruz D, Clark M, Cade A, Glucina T, Pritchard K, Fox M.

J Chiropr Educ. 2018 Oct;32(2):141-144. doi: 10.7899/JCE-17-25. Epub 2018 Aug 1.

14.

Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply.

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group.

Rheumatology (Oxford). 2018 Aug 1;57(8):1502-1503. doi: 10.1093/rheumatology/key170. No abstract available.

15.

New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.

Casian A, Sangle SR, D'Cruz DP.

Autoimmun Rev. 2018 Jul;17(7):660-664. doi: 10.1016/j.autrev.2018.01.016. Epub 2018 May 2. Review.

PMID:
29729450
16.

Physician-patient communication in rheumatology: a systematic review.

Georgopoulou S, Prothero L, D'Cruz DP.

Rheumatol Int. 2018 May;38(5):763-775. doi: 10.1007/s00296-018-4016-2. Epub 2018 Mar 26. Review.

17.

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

McCarthy EM, Sutton E, Nesbit S, White J, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2018 Mar 1;57(3):470-479. doi: 10.1093/rheumatology/kex395.

18.

Relapsing polychondritis: a clinical review for rheumatologists.

Kingdon J, Roscamp J, Sangle S, D'Cruz D.

Rheumatology (Oxford). 2018 Sep 1;57(9):1525-1532. doi: 10.1093/rheumatology/kex406. Review.

PMID:
29126262
19.

Cocaine and ANCA associated vasculitis-like syndromes - A case series.

Subesinghe S, van Leuven S, Yalakki L, Sangle S, D'Cruz D.

Autoimmun Rev. 2018 Jan;17(1):73-77. doi: 10.1016/j.autrev.2017.11.011. Epub 2017 Nov 3. Review.

PMID:
29108823
20.

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group.

Rheumatology (Oxford). 2018 Jan 1;57(1):e1-e45. doi: 10.1093/rheumatology/kex286. No abstract available.

21.

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group.

Rheumatology (Oxford). 2018 Jan 1;57(1):14-18. doi: 10.1093/rheumatology/kex291. No abstract available.

22.

Orbital Inflammation as a Presenting Sign for CREST Syndrome.

Hamed-Azzam SW, D'Cruz DP, Verity DH.

Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):e43-e45. doi: 10.1097/IOP.0000000000001007.

PMID:
28990976
23.

Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.

Poh YJ, Baptista B, D'Cruz DP.

Expert Rev Clin Immunol. 2017 Oct;13(10):925-938. doi: 10.1080/1744666X.2017.1371592. Review.

PMID:
28847197
24.

Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.

Cooray S, Zhang H, Breen R, Carr-White G, Howard R, Cuadrado M, D'Cruz D, Sanna G.

Lupus. 2018 Apr;27(4):670-675. doi: 10.1177/0961203317722849. Epub 2017 Aug 1.

PMID:
28764615
25.

Unilateral vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely preterm infants.

Pharande P, Karthigeyan S, Walker K, D'Cruz D, Badawi N, Luig M, Winlaw D, Popat H.

J Paediatr Child Health. 2017 Dec;53(12):1192-1198. doi: 10.1111/jpc.13632. Epub 2017 Jul 8.

PMID:
28688160
26.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1049. doi: 10.1093/rheumatology/kex218. No abstract available.

27.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1041-1043. doi: 10.1093/rheumatology/kex044. No abstract available. Erratum in: Rheumatology (Oxford). 2017 Jun 1;56(6):1049.

28.

Burden of illness in systemic lupus erythematosus: results from a UK patient and carer online survey.

Kent T, Davidson A, Newman D, Buck G, D'Cruz D.

Lupus. 2017 Sep;26(10):1095-1100. doi: 10.1177/0961203317698594. Epub 2017 Apr 13.

PMID:
28406053
29.

Neurological Manifestations of IgG4-Related Disease.

Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM.

Curr Treat Options Neurol. 2017 Apr;19(4):14. doi: 10.1007/s11940-017-0450-9. Review.

30.

Editorial: Cutting edge in systemic lupus erythematosus.

D'Cruz DP, Kuhn A.

Immunol Res. 2017 Apr;65(2):429-431. doi: 10.1007/s12026-017-8910-6. No abstract available.

31.

The funding lottery for potentially life-threatening rare diseases.

Roscamp JA, D'Cruz DP.

Rheumatology (Oxford). 2018 Jan 1;57(1):1-2. doi: 10.1093/rheumatology/kex004. No abstract available.

PMID:
28160005
32.

Systemic lupus erythematosus.

Shaikh MF, Jordan N, D'Cruz DP.

Clin Med (Lond). 2017 Feb;17(1):78-83. doi: 10.7861/clinmedicine.17-1-78.

33.

[18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study.

Fernando A, Pattison J, Horsfield C, D'Cruz D, Cook G, O'Brien T.

Eur Urol. 2017 Jun;71(6):926-933. doi: 10.1016/j.eururo.2016.10.046. Epub 2016 Nov 18.

PMID:
27876167
34.

Current and emerging treatment options in the management of lupus.

Jordan N, D'Cruz D.

Immunotargets Ther. 2016 Mar 2;5:9-20. doi: 10.2147/ITT.S40675. eCollection 2016. Review.

35.

Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment.

Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, D'Cruz D, Nagel E, Puntmann VO.

Int J Cardiol. 2016 Nov 1;222:717-726. doi: 10.1016/j.ijcard.2016.07.182. Epub 2016 Aug 3.

PMID:
27521546
36.

Burning vasculitis.

Chadha P, Hobday D, O'Connor EF, D'Cruz D.

BMJ Case Rep. 2016 Apr 26;2016. pii: bcr2016214654. doi: 10.1136/bcr-2016-214654.

37.

Impairment-targeted exercises for older adults with knee pain: a proof-of-principle study (TargET-Knee-Pain).

Wood LR, Blagojevic-Bucknall M, Stynes S, D'Cruz D, Mullis R, Whittle R, Peat G, Foster NE.

BMC Musculoskelet Disord. 2016 Jan 29;17:47. doi: 10.1186/s12891-016-0899-9.

38.

Bilateral reversible basal ganglia changes associated with dystonia and hemifacial spasms in central nervous system lupus.

Wu K, Christodoulou L, Siddiqui A, D'Cruz D, Andrews T.

Quant Imaging Med Surg. 2015 Dec;5(6):928-9. doi: 10.3978/j.issn.2223-4292.2015.03.17.

39.

Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.

Chan E, Sangle SR, Coghlan JG, D'Cruz DD.

Autoimmun Rev. 2016 Apr;15(4):375-8. doi: 10.1016/j.autrev.2016.01.003. Epub 2016 Jan 8. Review.

PMID:
26777307
40.

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1.

Lewis MJ, Vyse S, Shields AM, Zou L, Khamashta M, Gordon PA, Pitzalis C, Vyse TJ, D'Cruz DP.

Arthritis Res Ther. 2016 Jan 8;18:5. doi: 10.1186/s13075-015-0896-7.

41.

Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications.

Jordan N, D'Cruz D.

Ther Adv Musculoskelet Dis. 2015 Dec;7(6):234-46. doi: 10.1177/1759720X15601805. Review.

42.

Cutaneous lupus erythematosus.

Tull TJ, Pink AE, Benton EC, D'Cruz D.

Br J Hosp Med (Lond). 2015 Nov;76(11):C162-5. doi: 10.12968/hmed.2015.76.11.C162. Review. No abstract available.

PMID:
26551507
43.

Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.

Hannah J, Casian A, D'Cruz D.

Autoimmun Rev. 2016 Jan;15(1):93-101. doi: 10.1016/j.autrev.2015.09.006. Epub 2015 Sep 30. Review.

PMID:
26427983
44.

Association of Lupus Anticoagulant With Long-Term Damage Accrual in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Jordan N, D'cruz DP.

Arthritis Care Res (Hoboken). 2016 May;68(5):711-5. doi: 10.1002/acr.22723.

45.

Autoimmune rheumatic disease and sleep: a review.

Sangle SR, Tench CM, D'Cruz DP.

Curr Opin Pulm Med. 2015 Nov;21(6):553-6. doi: 10.1097/MCP.0000000000000215. Review.

PMID:
26402614
46.

Correction. Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus.

Fraser LD, Zhao Y, Lutalo PM, D'Cruz DP, Cason J, Silva JS, Dunn-Walters DK, Nayar S, Cope AP, Spencer J.

Eur J Immunol. 2015 Sep;45(9):2701. doi: 10.1002/eji.201570097. No abstract available.

47.

Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.

Jordan NP, D'Cruz DP.

Expert Opin Drug Metab Toxicol. 2015;11(10):1635-45. doi: 10.1517/17425255.2015.1077808. Epub 2015 Sep 1. Review.

PMID:
26327145
48.

Livedo Reticularis: An Enigma.

Sangle SR, D'Cruz DP.

Isr Med Assoc J. 2015 Feb;17(2):104-7. Review.

49.

Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study.

Hazra N, Dregan A, Charlton J, Gulliford MC, D'Cruz DP.

Rheumatology (Oxford). 2015 Dec;54(12):2181-7. doi: 10.1093/rheumatology/kev240. Epub 2015 Jul 17.

PMID:
26187053
50.

Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus.

Fraser LD, Zhao Y, Lutalo PM, D'Cruz DP, Cason J, Silva JS, Dunn-Walters DK, Nayar S, Cope AP, Spencer J.

Eur J Immunol. 2015 Aug;45(8):2409-19. doi: 10.1002/eji.201545599. Epub 2015 Jun 24. Erratum in: Eur J Immunol. 2015 Sep;45(9):2701.

Supplemental Content

Loading ...
Support Center